Accelmed
Overview
Accelmed is a private equity firm focused on acquiring and investing in U.S. commercial-stage, lower middle-market HealthTech companies, including medical devices, diagnostics, digital health, and technology-enabled healthcare services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Click Therapeutics | Oct 2021 | Series B | Lead |
| Endoluminal Solutions Inc. | May 2019 | Series I | Co-investor |
| AiCure | Nov 2019 | Series C | Co-investor |
| Momentis Surgical | Apr 2021 | Series D | Co-investor |
| Digma Medical | May 2022 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Uri Geiger
Founder & Managing Partner
Daniel Cohen
Venture Partner
Irit Yaniv
Partner
Steve Rubin
Partner
Maria Forero
Senior Investment Principal Advisor At Accelmed Partners
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Accelmed based?
Accelmed is headquartered in New York City, New York, United States.
When was Accelmed founded?
Accelmed was founded in 2009.
How many portfolio companies does Accelmed have?
Accelmed has 20 portfolio companies in Caplight's dataset.
What are some companies in Accelmed's portfolio?
Portfolio companies visible on Caplight include Click Therapeutics, Endoluminal Solutions Inc., AiCure, Momentis Surgical, Digma Medical.
What was Accelmed's most recent investment shown here?
Accelmed's most recent investment in this portfolio sample was in Digma Medical in 2022.
What sectors does Accelmed focus on?
Accelmed focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does Accelmed focus on?
Accelmed typically invests at the MultiStage stage.
What is Accelmed's AUM?
Accelmed's assets under management are estimated between $630.0M and $630.0M.